INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland. Józef Woźny- President. Pharmaceutical Sector in Poland.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
T.U. Federation of Chemical, Glass and CeramicIndustriesin Poland.
Józef Woźny- President
It provides public access to medicines of good qualitywith benefit price(more than 50% of the packages in the market comes from domestic plants).
Only one plant-PolfaTarchomin remains in the hands of the Treasury.
Domestic pharmaceutical companies more than 60% of the profit is investing. Theseinvestments have allowed companies such as for:
Domestic pharmaceutical companies spend on research and development, 13% of the profits, where the average for the processing industry in Poland is 3.5%.
The export of medicines toEU countries are 75.6%. Among the countries to which exported the Polish medicine complex, the majority were:
Germany (15.5% of Polish exports) and the United Kingdom,
France and Russia (about 9% of Polish foreign sales).
Domestic pharmaceutical industry employs approx. 23 000 peoples.
Salary in the manufacturing industry was 3 250.00 PLN in the pharmaceutical industry 5 319.00 PLN.
Trade Union membership in the pharmaceutical industry is in the range of 30-35%.
In the factories functioning Works Collective LabourAgreements.
Where are the European Works Council representatives of Polish pharmaceutical companies are authorized.
Works Council functioning of each plant.
Multi-establishment collective agreement is not signed, has not given its consent Employers Association of Pharmaceutical Industries.
Sponsoring of sport and cultural news
Organized of seminars and science conferences
Information actions for the patients
Investments in environmental
Free diagnostics for patients
Companies don’t take activities on this field.
The introduction a new products in market
The overall increase in wealth of the society
The access to reimbursement
The access to investment funds
Improving the law system
The marketing actions
Improving quality of products
Output from outside the polish market
Increasing health consciousness of Poles
Increasing of amount of sales representatives
THANK YOU FOR ATTENTION!
Presentation preparedon the basis of the documentation:
1. PolishEmployersAssociation in the Pharmaceutical Industry
2. Department of Economic Information- Invest In Poland
3. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland